cobicistat - medicine shortage information

Back to ALL shortages and discontinuations    Back to CRITICAL shortages and discontinuations

If you are having difficulty obtaining a medicine that has been prescribed to you, talk to your doctor or pharmacist to discuss suitable options to continue your care.

More information about medicine shortages and how to access alternative medicines is available at the Medicine Shortages hub

Product details Supply Impact Dates Further Details
EVOTAZ atazanavir/cobicistat 300 mg/150 mg film coated tablets bottle
AUST R: 229476
Active ingredients:
atazanavir
cobicistat

Dosage form:
Tablet, film coated

Sponsor:
Bristol-Myers Squibb Australia Pty Ltd

Phone:
1800 067 567

Deletion from market:
31 Mar 2027

Shortage status:
To be discontinued

Availability:
Reduction in supply until supply is exhausted

Reason:
Commercial Changes / Commercial viability

Management action:
Patients are advised to consult their healthcare professional to discuss their options.